Results 141 to 150 of about 289,170 (184)

Exploratory Profiling of ABC-Family Genes Identifies a Candidate Score in Pediatric Neuroblastoma. [PDF]

Cancer Genomics Proteomics
Motomura H, Akimoto K, Yamazaki S.
europepmc   +1 more source

MIR17HG Expression Is Transcriptionally Regulated by PAX3::FOXO1 and MYCN and Is Necessary for Oncogenic Activity in Fusion-Positive Rhabdomyosarcoma. [PDF]

Mol Cancer Res
Zargar S, Raut PK, Kim H, Boudjadi S, Hoffman RA, Stanton BZ, Barr FG.   +6 more
europepmc   +1 more source

The role of personalised medicine in treating high-risk neuroblastoma in paediatric patients. [PDF]

Oncol Rev
Ammeti D, Curci D, Franzin M, Rabusin M, Zanchetta ME, Fabretto A.   +5 more
europepmc   +1 more source

Clinical characteristics and treatment outcomes of neuroblastoma with pulmonary metastases. [PDF]

World J Pediatr Surg
Wei Q, He G, Wu B, Li X, Liu J, Su Y, Yu T, Yang W, Yang S.   +8 more
europepmc   +1 more source

Spinal Cord Ependymomas With MYCN Amplification Show Aggressive Clinical Behavior.

Journal of Neuropathology and Experimental Neurology, 2019
Adult spinal cord ependymomas are typically low grade and have a relatively favorable clinical course following gross total resection. We report 4 cases of anaplastic spinal cord ependymoma with MYCN amplification, an exceptionally rare finding.
Aditya Raghunathan, Timothy J Kaufmann, Robert Jenkins   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Secondary enucleated retinoblastoma with MYCN amplification

Ophthalmic Genetics, 2021
Background: Absence of RB1 mutation is rare in retinoblastoma and MYCN amplifications were recently identified in a subset of aggressive retinoblastomas occurring in infants. Here we describe not only the clinical phenotype of MYCN retinoblastoma at presentation, but also the tumor response to the first attempt of conservative management in this ...
Moulin, A.P., Stathopoulos, C., Marcelli, F., Schoumans Pouw, J., Beck-Popovic, M., Munier, F.L.   +5 more
openaire   +3 more sources

MYCN AMPLIFICATION IN MEDULLOBLASTOMA

Pediatric Pathology & Molecular Medicine, 1998
Prominent neuronal differentiation and MYCN amplification occur only in a small percentage of medulloblastomas (primitive neuroectodermal tumor of the cerebellum). In this article, we describe two medulloblastomas that showed a striking degree of neuronal differentiation with islands of mature neurons associated with abundant neuropil.
Venita Jay, Paula Marrano, Maria Zielenska   +2 more
openaire   +2 more sources

MYCN Amplification by Differential PCR

Pediatric Hematology and Oncology, 1993
A method is described to estimate MYCN (N-myc) oncogene amplification in neuroblastoma by the technique of differential polymerase chain reaction (PCR). The technique is quicker than conventional Southern blotting techniques and does not require radioactive materials.
S N, Huddart, J R, Mann, A G, McGukin, R, Corbett   +3 more
openaire   +2 more sources